Skip to main content
Log in

Belatacept verbessert Langzeitverlauf nach Nierentransplantation

Belatacept improves long-term outcome after kidney transplantation

  • Für Sie gelesen
  • Published:
Der Nephrologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Vincenti F, Rostaing L, Grinyo J, Rice K, Steinberg S, Gaite L, Moal MC, Mondragon-Ramirez GA, Kothari J, Polinsky MS et al (2016) Belatacept and long-term outcomes in kidney transplantation. N Engl J Med 374:333–343. doi:10.1038/ejcn.2015.174

    Article  CAS  PubMed  Google Scholar 

  2. Rostaing L, Vincenti F, Grinyo J, Rice KM, Bresnahan B, Steinberg S, Gang S, Gaite LE, Moal MC, Mondragon-Ramirez GA et al (2013) Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study. Am J Transplant 13:2875–2883

    Article  CAS  PubMed  Google Scholar 

  3. Vincenti F, Charpentier B, Vanrenterghem Y, Rostaing L, Bresnahan B, Darji P, Massari P, Mondragon-Ramirez GA, Agarwal M, Di Russo G et al (2010) A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 10:535–546

    Article  CAS  PubMed  Google Scholar 

  4. Vincenti F, Larsen CP, Alberu J, Bresnahan B, Garcia VD, Kothari J, Lang P, Urrea EM, Massari P, Mondragon-Ramirez G et al (2012) Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients. Am J Transplant 12:210–217

    Article  CAS  PubMed  Google Scholar 

  5. Florman SM, Rial M, Medina J (2015) Final results from the BENEFIT-EXT trial: a 7 year follow-up of belatacept treated patients. Am J Transplant 15(Suppl 3):Abstract

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Lutz.

Ethics declarations

Interessenkonflikt

J. Lutz gibt an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

T. Feldkamp, Kiel

J. Lutz, Mainz

L. T. Weber, Köln

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lutz, J. Belatacept verbessert Langzeitverlauf nach Nierentransplantation. Nephrologe 11, 355–356 (2016). https://doi.org/10.1007/s11560-016-0079-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-016-0079-9

Navigation